Meeting the Demand for Unrelated Donors in the Midst of the COVID-19 Pandemic: Rapid Adaptations by the National Marrow Donor Program and Its Network Partners Ensured a Safe Supply of Donor ProductsJeffery J. Auletta, Steven M. Devine, Jeni Newman et al.|Transplantation and Cellular Therapy|2020Cited by 27
Neither COVID-19, nor cryopreservation, prevented allogeneic product infusion: A report from the National Marrow Donor ProgramNosha Farhadfar, Heather E. Stefanski, Jeni Newman et al.|Frontiers in Immunology|2022Cited by 10
Neither COVID-19, Nor Cryopreservation, Prevented Allogeneic Product Infusion: A Report from the National Marrow Donor ProgramHeather E. Stefanski, Steven M. Devine, J. Philip Miller et al.|Blood|2021Cited by 2